BioSpace News Archive

Pharvaris announced the annual general meeting of shareholders will take place on Wednesday, June 29, 2022, at 16:00 CEST.

MAIA Biotechnology, Inc. , a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that MAIA has entered into a research and collaboration agreement with the Nationwide Children’s Hospital to evaluate the potential of THIO in combination with current standard-of-care therapies for cancer.

Momentum continues to build for Dren Bio after successfully forming highly experienced senior leadership team and earlier this year announcing research collaboration and license deal with Pfizer.

The South African Health Products Regulatory Authority has approved a sweet-tasting, heat-stable, ‘4-in-1' fixed-dose combination of four antiretroviral treatments composed of abacavir, lamivudine, lopinavir, and ritonavir that is specifically designed for infants and young children with HIV.

Pre-clinical proof-of-concept demonstrated in a disease model.

AVM Biotechnology, a clinical stage company advancing AVM0703 in the treatment of Non-Hodgkin’s Lymphoma (NHL)/Leukemia, today announced that it has been awarded a Phase II Small Business Innovative Research (SBIR) grant.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today the pricing of an underwritten offering (the “Offering”) of 25,464,483 of its ordinary shares at an offering price of $2.15 per ordinary share, and, to RA Capital Management, L.P. in lieu of ordinary shares.

Hollister Incorporated, a global medical device company has been awarded an AscenDrive contract with Premier, Inc. AscenDrive is Premier’s new program designed to drive commitment and savings for members through aggregated purchasing of high quality products and services.

Xenco Medical has expanded its ASC surgical device portfolio through the FDA clearance and launch of its Multilevel CerviKitTM,, an expansion of Xenco Medical’s breakthrough single-use cervical spine technology to include a comprehensive suite of implants and single-use instruments for 2, 3, and 4 level anterior cervical spine procedures.

Advanced Instruments, a global provider of scientific and analytical instruments and services for bioprocessing, is excited to announce the implementation of the complete Solentim Ecosystem at Wheeler Bio in Oklahoma City, OK.